Why Shares of Cassava Sciences Soared This Week
Cassava bounced back from hitting a 52-week low to start the week.
Source: fool.com
Page 30 - Cassava Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cassava Sciences Today - Breaking & Trending Today
Buy Rating for Cassava Sciences: Rapid Alzheimer's Trials Progress and Strong Financial Health
Cassava Sciences (SAVA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy...
Source: businessinsider.com
Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer's Disease
804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical TrialA Second Pivotal Phase 3 Clinical Trial Is Expected to Complete Enrollment Q4 2023, With a Target Enrollment of Approximately...
Source: marketscreener.com
Cassava Sciences (NASDAQ:SAVA) Reaches New 12-Month Low at $16.41
Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $16.41 and last traded at $16.54, with a volume of 122449 shares traded. The stock had previously closed at $16.64. Analysts Set New Price Targets Separately, HC Wainwright reiterated […]
Source: etfdailynews.com
Cassava Sciences (NASDAQ:SAVA) Trading Up 5.3%
Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) shares were up 5.3% on Wednesday . The stock traded as high as $19.18 and last traded at $19.17. Approximately 525,500 shares were traded during mid-day trading, a decline of 45% from the average daily volume of 962,936 shares. The stock had previously closed at $18.20. Wall […]
Source: etfdailynews.com